Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Trading Update

4 Apr 2016 07:00

RNS Number : 9656T
First Derivatives PLC
04 April 2016
 

4 April 2016

 

First Derivatives plc

("FD" or the "Group")

 

Trading Update

 

FD (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services, announces continued strong trading in the second half of its financial year to 29 February 2016. As a result the Board now expects the financial performance for the full year to be comfortably ahead of current consensus forecasts of £109.5m of revenue and £22.1m of EBITDA.

 

Consulting

Consulting revenue continued to grow strongly in the second half driven by the Group's high level of contracted revenue and a number of important new customer wins. This included a number of projects where FD is to act as a strategic partner to assist major investment banks with change programmes. This is in line with our business model under which we seek to grow these initial wins into multi-year assignments.

 

Software

We continue to see strong demand in our traditional financial services market across our range of software products, signing a record number of contracts in the second half of our financial year. Due to the annual recurring nature of our software license contracts the full impact of these wins will be reflected in the financial year ended February 2017. Outside financial services, the Group continues to make good progress with potential customers and partners for its Kx technology products especially for digital marketing and sensor analytics applications.

 

 

Brian Conlon, Chief Executive Officer of FD, commented: "We have made strong progress over the course of the past year and are well placed to continue to do so. In consulting our increasing scale and breadth of expertise is enabling us to get involved earlier in the change lifecycle within our clients, leading to deeper and more strategic relationships. In software, our market-leading capability in analysing large volumes of data in real time is increasingly understood and as a result we have experienced an acceleration of contract wins during the past year. We look forward to updating shareholders further when we announce our full year results."

 

 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Dominic Emery

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 4000

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

 

 

Walbrook PR

Paul Cornelius / Nick Rome / Helen Cresswell / Sam Allen

 

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,500 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUAOVRNNASRAR
Date   Source Headline
2nd Jul 20187:02 amRNSFD to buy out minority Kx Systems shareholders
29th Jun 201811:32 amRNSTotal Voting Rights
27th Jun 20181:03 pmRNSAGM Statement
15th Jun 20186:01 pmRNSHolding(s) in Company
8th Jun 20188:00 amRNSEnterprise Securities Market Notice
7th Jun 201810:43 amRNSHolding(s) in Company
5th Jun 20184:51 pmRNSNotice of AGM
1st Jun 20184:14 pmRNSIssue of Equity
22nd May 20187:00 amRNSPreliminary results for the year ended 28 Feb 2018
17th May 20187:02 amRNSKx provides rapid access to unstructured data
25th Apr 20187:00 amRNSTrading update and Notice of Results
3rd Apr 201810:00 amRNSTotal Voting Rights
23rd Mar 20187:00 amRNSEnterprise Securities Market Notice
19th Mar 201810:09 amRNSIssue of Equity
28th Feb 20189:01 amRNSTotal Voting Rights
20th Feb 20187:00 amRNSContract Win in Gaming
7th Feb 20187:00 amRNSEnterprise Securities Market Notice
1st Feb 20185:23 pmRNSIssue of Equity
31st Jan 20183:40 pmRNSTotal Voting Rights
15th Jan 20187:00 amRNSAppointment of Non-Executive Director
4th Jan 20187:00 amRNSEnterprise Securities Market Notice
29th Dec 20177:00 amRNSTotal Voting Rights
27th Dec 20177:00 amRNSIssue of Equity
19th Dec 20174:06 pmRNSDirector/PDMR Shareholding
18th Dec 20174:07 pmRNSIssue of Equity
14th Dec 20177:00 amRNSEnterprise Securities Market Notice
11th Dec 20177:00 amRNSTelco Acquisition
7th Dec 20177:00 amRNSEnterprise Securities Market Notice
1st Dec 20174:31 pmRNSIssue of Equity
30th Nov 20178:36 amRNSTotal Voting Rights
22nd Nov 201710:35 amRNSHolding(s) in Company
21st Nov 20174:54 pmRNSHolding(s) in Company
16th Nov 20177:00 amRNSEnterprise Securities Market Notice
10th Nov 201712:32 pmRNSIssue of Equity and Dividend Timetable Amendment
7th Nov 20177:00 amRNSHalf Yearly Report
6th Nov 20177:00 amRNSKx selected by Red Bull Racing
13th Oct 20177:00 amRNSNotice of Results
2nd Oct 20179:09 amRNSTotal Voting Rights
19th Sep 20177:00 amRNSMajor Machine Learning Investment in Kx Technology
5th Sep 20177:00 amRNSEnterprise Securities Market Notice
30th Aug 20173:04 pmRNSIssue of Equity
23rd Aug 201712:20 pmRNSHolding(s) in Company
31st Jul 201711:58 amRNSTotal Voting Rights
28th Jul 20177:00 amRNSEnterprise Securities Market Notice
25th Jul 20177:00 amRNSHolding(s) in Company
24th Jul 20174:26 pmRNSIssue of Equity from exercise of Share Options
7th Jul 20177:00 amRNSEnterprise Securities Market Notice
3rd Jul 20174:23 pmRNSIssue of Equity from exercise of Share Options
30th Jun 201710:48 amRNSTotal Voting Rights
23rd Jun 20171:50 pmRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.